Vaginal Swabs Clinical Information Why? Murray Robinson

Slides:



Advertisements
Similar presentations
Appraising a diagnostic test study using a critical appraisal checklist Mahilum-Tapay L, et al. New point of care Chlamydia Rapid Test – bridging the gap.
Advertisements

PREVALENCE OF CHLAMYDIA TRACHOMATIS, NEISSERIA GONORRHOEAE AND TRICHOMONAS VAGINALIS IN YOUNG WOMEN IN KENYA USING THE GEN-PROBE APTIMA ASSAYS J Moncada.
Mark Gilhooly ST2 O&G. Key health issues include unintended pregnancy and STI STI diagnosis – rise by 2% since 2011 with 427,000 cases in 2011 Young heterosexuals.
CASE Mrs Ford is a 29 years old lady who has been complaining of vaginal discharge for the past 3 days. Otherwise she is asymptomatic. Her PMH includes.
Recommendations for STD Clinical Preventive Services for Persons Living with HIV/AIDS.
HIV/AIDS & STI Policy Guideline Clinical Management of Sexually Transmissible Infections DRAFT - 20 April 2001 FLOWCHARTS DEPARTMENT OF HEALTH Republic.
Determining the timing of Chlamydia trachomatis test of cure Sarah K Tillman, MD Gweneth Lazenby, MD MSCR MUSC Obstetrics and Gynecology.
Antimicrobial Resistance in N. gonorrhoeae – An Overview 2014 INTRODUCTION Progressive antimicrobial resistance in Neisseria gonorrhoeae is an emerging.
Self-Collected Vaginal Specimens for the Detection of Multiple STIs in Adolescent Detainees Cynthia M. Holland, M.D., M.P.H., Harold C. Wiesenfeld, M.D.,
Pelvic inflammatory disease
CDC National Infertility Prevention Project Laboratory Update Region I Wells Beach, Maine June 1-3, 2009 Richard Steece, Ph.D., D(ABMM)
Antimicrobial Resistance in N. gonorrhoeae: In Brief 2014 INTRODUCTION Increased action is needed to help prevent and control gonorrhea. Worldwide antimicrobial.
Region I Advisory Board Meeting Wells Beach, ME June 9, 2008 Use and Verification of STD Nucleic Acid Amplification Tests for non-FDA Cleared Clinical.
2014 PATIENT HISTORY How would you diagnose and screen Miranda? How would you treat Miranda? Are there any additional steps you would take? Antimicrobial.
The laboratory investigation of urinary tract infections
BATERIA/VIRUSES.! CHLAMYDIA BY: ASHLEY FROST, JUANA GUZAMN & FINESSE MATOS.
Gonorrhea SARAH LANGE NICK LETT ANDREA LEWIS WILLIAM LEWIS MELISSA LIVERMORE.
Chlamydia trachomatis testing Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Chlamydia trachomatis? Chlamydia.
CHLAMYDIA.
Sexual Risk Behaviors and Sexually Transmitted Infection (STI) Prevalence in an Outpatient Psychiatry Clinic LH Bachmann 1,2, J Feldman 1, Y Waithaka 1.
Use of an Internet-Based Self-Screening Program to Screen for Chlamydia and Gonorrhea Wendy Voet On Behalf Of Charlotte A. Gaydos and Karen Dwyer, Mathilda.
The Primary Care Consultation and Sexual Health. Aims of today Why is it important? Overcoming barriers Assessing risk Reducing risk Scenarios.
Alice Beckholt RN, MS, CNS
Sexually Transmitted Infections: UK National Screening and Testing Guidelines BASHH Guidelines 2006 Dr Olwen Williams.
Region I Laboratory Update CDC National Infertility Prevention Project Boston, Massachusetts November 15, 2010 Richard Steece, Ph.D., D(ABMM) Laboratory.
When to Confirm a Positive NAAT An additional test should be considered after a positive screening test if a false-positive screening test would result.
PID Normal Human Fallopian Tube Tissue C. trachomatis Infection (PID)
Evaluation of Presumptive Treatment Recommendation for Asymptomatic Anorectal Gonorrhoea and Chlamydia Infections in At-Risk Kenyan MSM IAS 24 July 2012.
Reproductive block Objectives Name various etiological agents causing sexually transmitted diseases (STD) Describe the clinical presentations.
A R Markos FRCOG FRCP A R Markos FRCOG FRCP Consultant in Genito Urinary Medicine and Sexual Health Consultant in Genito Urinary Medicine and Sexual Health.
 Sexually Transmitted Disease or Sexually Transmitted Infection? What is a Sexually Transmitted?
Sexual History Ejay Harris. Where to start? WIPE Open ended question……vaginal discharge.
Prevalence of Chlamydia and Gonorrhea Among Patients With Genital Ulcer Disease in Zimbabwe: Potential Implications for Syndromic Management More Mungati:
Role of the Practice Nurse Sexual Health in General Practice Jane Deehan RGN.
What is Chlamydia?. Chlamydia Bacterial sexually transmitted infection (STI) Most common STI throughout the world 1 in 10 sexually active 15 – 25 years.
STI Management- When to refer? Dr Vendela McNamara Leicester Sexual Health Service.
 Sexually Transmitted Disease or Sexually Transmitted Infection? What is a Sexually Transmitted?
Please take a seat CLINIC WAITING ROOM. Carolyn Murray Donna Tilley Margy Ewing Ruth Mursa.
What is pelvic inflammatory disease (PID)? Pelvic inflammatory disease (PID) is an infection in the female reproductive organs. Normally, the cervix prevents.
Information & Resource Pack CHLAMYDIA. Guidance Notes Press F5 to view as slideshow – all links will be live This pack links to curriculum chapters: Healthy.
The Dublin Well Woman Centre and The National Virus Reference Laboratory  Approved by ICGP Ethics Committee.
Evaluation of 5 different tests for Trichomonas vaginalis infection and cost effective planning for clinical implementation B. Nathan 1, J Appiah 2, D.
Human Immunodeficiency Virus Infection among Patients with Sexually Transmitted Infections in Zimbabwe: More Mungati: MBChB, MPH Zimbabwe Ministry.
Common infections Dr Arlo Upton Microbiologist Medical Director Labtests Professor Bruce Arroll Department of General Practice and Primary Health Care.
CHLAMYDIA TRACHOMATIS – DIAGNOSIS AND MANAGEMENT Jess Gaddie (adapted from presentation by Rachel Coyne)
How can Health Care Assistants & Practice Nurses increase STI & HIV screening in primary care Dr Jane Hutchinson 5 th March 2015.
Risk Behaviour, Health Care Access and Prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoea in a population based sample of.
Gonorrhea Testing, Diagnosis and Treatment
Case Study 2 Microbiological Testing for Chlamydia and Gonorrhea
Rectal chlamydia infection in women Have we been missing the point?
The Zimbabwe STI Etiology Study
Vaginal Infections NURS 541: Women’s Healthcare – Diagnosis and Management.
Specialty Doctor in Sexual Health
Mycoplasma genitalium and macrolide resistance in pelvic inflammatory disease (PID) Gillian Dean1, Jennifer Whetham1, Suneeta Soni1, Rachel Pitt2, Sarah.
Topic Gonorrhea Diseases
Gonorrhoea & PID PHCP 402 By K S Labaran.
Dr.Jyothi Ranganathan Head lab operations SRL Ltd Bangalore
Appraising a diagnostic test study using a critical appraisal checklist Mahilum-Tapay L, et al. New point of care Chlamydia Rapid Test – bridging the gap.
Sexual Medicine Josie and Jess
LECTURE TOPIC: VAGINITIS
Non-Viral STD of Major significance
Richard Steece, Ph.D., D(ABMM)
Appraising a diagnostic test study using a critical appraisal checklist Mahilum-Tapay L, et al. New point of care Chlamydia Rapid Test – bridging the gap.
WOMEN’S HEALTH Sexually Transmitted Infections & Cervical Screening
Vaginal and endocervical microorganisms in symptomatic and asymptomatic non- pregnant females: risk factors and rates of occurrence  C. Tibaldi, N. Cappello,
Medical-Surgical Nursing: Concepts & Practice
Impact of pads and cups on school dropout, sexually transmitted infections (STIs) and reproductive tract infections (RTIs) by 9 months duration. §Adjusted.
Richard Steece, Ph.D., D(ABMM) National Infertility Prevention Project
Impact of pads and cups on school dropout, STI and RTI
Presentation transcript:

Vaginal Swabs Clinical Information Why? Murray Robinson Microbiology & Molecular Diagnostic Lead of Specialty

Why do you collect a Vaginal swab? Routine check Clinical abnormality * Clinical history * Because I always do Just in case Because I was there Because the patient asked *With relevant clinical information

Clinical Information Good Reject STI Risk only STI check Discharge Discharge with STI risk ? Thrush ?BV ?Trichomonas Pre TOP Post TOP Post surgery Post partum Miscarriage Pelvic pain ?PID Sexual abuse/assault STI check New partner UPSI Sexually active No clinical details No relevant clinical details Routine screen Pregnant ?Infection Symptomatic Asymptomatic screening NOTE: The Yellow CT/NG NAAT tube is never rejected. CT/NG NAAT = Chlamydia / Gonorrhoea Nucleic Acid Amplification Test

Clinically guided testing eSwab (pink) – 4 possible tests Gram stain – BV, Yeast, Leucocytes Trichomonas culture Culture – “wound” Gp B Strep. screen (pregnant, 35-37 weeks) Roche tube (yellow) CT/NG NAAT – STI screen / STI symptoms CT/NG NAAT = Chlamydia / Gonorrhoea Nucleic Acid Amplification Test

Vaginal swab collection Asymptomatic – no STI risk No clinical reason for testing No swabs No tests – STI risk Clinical information of “STI screen” / “STI check” Yellow CT/NG tube, consider Trichomonas (Pink eSwab) Tests performed: - CT/NG NAAT - Trichomonas culture (if Pink eSwab received) Symptomatic Provide clinical symptoms & reason for testing Pink eSwab only - Gram stain for BV, Yeast - Culture (only if clinical details indicate) Provide clinical symptoms & indicate STI risk Pink eSwab & Yellow CT/NG tube - Trichomonas culture Example clinical details: Routine Pregnant Example clinical details: STI screen STI check UPSI Sexually active New partner Example clinical details: Discharge ?Thrush ?BV Post partum infection Post surgery Example clinical details: Discharge ?STI Pre TOP Post TOP infection Pelvic pain ?PID Sexual abuse / assault CT/NG NAAT = Chlamydia trachomatis / Neisseria gonorrhoeae nucleic acid amplification test; STI = Sexually transmitted infection; BV = Bacterial vaginosis References: http://nzshs.org/docman/guidelines/principles-of-sexual-health-care/148-sexual-health-check-summary/file http://www.bpac.org.nz/resources/handbook/sti/sti.asp?artID=1

Reject comment No clinical details have been provided for laboratory testing of this vaginal swab (trichomonas testing is now NOT possible). - If trichomonas infection is clinically suspected, a repeat swab with specific request is required. - If yeast and BV testing is required provide relevant details. - If chlamydia/gonorrhoea tube was submitted this testing will be performed. (See Clinical Update; Laboratory Processing of Vaginal Swabs - July 2016).

Bad Practise Story Routine smear Because I was there: Vaginal swab – routine Vaginal swab – CT/NG Chlamydia trachomatis (CT) weak positive 3/5 tests Why were Microbiology swabs collected?

Why Clinical Information? Tests performed determined by clinical information Best practise Reduces unnecessary testing Reduces unnecessary treatment Reduces bacterial resistance Enables introduction of new technologies Trichomonas NAAT Other NAAT’s

Trichomonas NAAT Trial Trial to start late May / early June Assess suitably of test Identify high risk cohort Sustainable business case If successful Stop Trichomonas culture Replace with selective Trichomonas NAAT Review NAAT collection tube(s)

http://www.bpac.org.nz/resources/handbook/sti/sti.asp?artID=1

http://nzshs.org/docman/guidelines/principles-of-sexual-health-care/148-sexual-health-check-summary/file

Acknowledgements Microbiology team Dr Michael Addidle Dr Vani Sathyendran You for listening